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Background: Numerous studies have demonstrated the importance of statins in prevention of cardiovascular events among patients with coronary 
artery disease. However, whether statins reduce target lesion revascularization (TLR) after drug-eluting stent (DES) implantation was not addressed. 
This study aimed to evaluate the influence of statin therapy on the incidence of early TLR and late TLR “Late catch up phenomenon” after DES 
implantation.
Methods: A total of 12,824 patients undergoing sirolimus-eluting stent (SES) implantation were identified from the J-Cypher registry. Patients were 
divided into 2 groups according to the use of statins at hospital discharge (Statin group; 6208 patients, No-statin group; 6498 patients). Five years 
clinical outcomes were compared between the 2 groups and compared with period(within one year and beyod one year)
Results: Patients with statin had lower all-cause (9.1% vs 18.3%; p<0.0001) as compared with those without statin. TLR rate was significantly 
lower in patients with statin (12.7% vs 15.2%, p<0.0001). Early TLR within one year (6.5% vs 8.1%, p=0.0006) Late TLR beyond one year (8.4% 
vs 10.0%, p=0.0006). After multivariate analysis with 25 co-variables, statin therapy remained as independent predictors of reduced all-cause 
mortality (relative risk ratio (RR) 0.63, 95% confidence interval (CI) 0.56-0.73, p<0.0001) and Early TLR within one year (RR 0.84, 95% CI 0.72-0.99, 
p=0.041) Late TLR beyond one year (RR 0.84, 95% CI 0.72-0.99, p=0.0257).
Conclusions: Statin therapy was indipendent predictor of ealy TLR and late TLR ”late catch up phenomenon” after SES implantation.
